| Literature DB >> 26666588 |
I Re Lee1,2, Jae Il Shin1,2, Se Jin Park3, Ji Young Oh1, Ji Hong Kim1.
Abstract
Mean platelet volume (MPV) has not yet been well-established in urinary tract infection (UTI). The purpose of this study was to evaluate the role of MPV as an acute phase reactant in children with UTI. Data from 118 young children (<2 years) with UTI between 2012 and 2013 were grouped as acute pyelonephritis (APN) and lower UTI according to the dimercaptosuccinic acid (DMSA) scan abnormalities. MPV, platelet distribution width (PDW) platelet count, and other infection markers (white blood cell [WBC] count, erythrocyte sedimentation rate [ESR], and C-reactive protein [CRP]) were measured. WBC (P = 0.001), ESR (P = 0.005), CRP (P < 0.001) and MPV levels (P = 0.011) were significantly higher in the APN group than those in the lower UTI group. MPV positively correlated with PDW, CRP and negatively with platelet count. Multiple logistic regression analyses showed that CRP and MPV were independent predictive factors for APN patients. However, the area under the Receiver Operating Characteristic (ROC) curve analysis for MPV was lower than CRP. Our results suggest that MPV can be an inflammatory marker in UTI, but the predictive value of MPV was not superior to CRP in the diagnosis of APN.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26666588 PMCID: PMC4678298 DOI: 10.1038/srep18072
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic data, laboratory and imaging findings of UTI patients with or without DMSA scan abnormality.
| DMSA scan abnormalities (n = 62) | Normal DMSA scan (n = 56) | ||
|---|---|---|---|
| Age (months) | 5.4 ± 4.6 | 4.1 ± 2.0 | 0.059 |
| Sex (M:F) | 44 : 18 | 42 : 14 | 0.623 |
| Duration of fever (days) | 2.2 ± 1.1 | 2.0 ± 1.1 | 0.352 |
| Laboratory findings | |||
| WBC (/μL) | 17,608 ± 5,712 | 14,185 ± 5,210 | 0.001 |
| Hb (g/dL) | 10.9 ± 1.0 | 11.2 ± 1.0 | 0.082 |
| PLT (X103/μL) | 482 ± 195 | 472 ± 139 | 0.742 |
| ESR (mm/hr) | 53.1 ± 35.0 | 37.0 ± 24.8 | 0.005 |
| CRP (mg/L) | 84.1 ± 62.1 | 36.7 ± 25.8 | <0.001 |
| PDW (%) | 44.8 ± 6.7 | 45.7 ± 6.5 | 0.451 |
| MPV (fL) | 7.4 ± 0.5 | 7.2 ± 0.5 | 0.011 |
| Imaging findings | |||
| Abnormal USG | 48 (77.4%) | 35 (62.5%) | 0.076 |
| Abnormal VCUG | 22 (35.5%) | 7 (12.5%) | 0.004 |
DMSA: dimercaptosuccinic acid, WBC: white blood cell, Hb: hemoglobin, PLT: platelet, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, PDW: platelet distribution width, MPV: Mean platelet volume, USG: ultrasonography, VCUG: voiding cystourethrogram.
Figure 1Correlation among mean platelet volume (MPV), (A) platelet distribution width (PDW), (B) C-reactive protein (CRP), and (C) platelet count in UTI patients.
Multiple logistic regression analysis of laboratory parameters associated with renal cortical defects on 99mTechnetium-dimercaptosuccinic acid (DMSA) scintigraphy.
| Odds ratio | 95% CI | ||
|---|---|---|---|
| CRP (mg/L) | 1.026 | 1.013–1.040 | < 0.001 |
| MPV (fL) | 2.393 | 1.019–5.620 | 0.045 |
CRP: C-reactive protein, MPV: Mean platelet volume.
Figure 2Receiver operating characteristic curve of mean platelet volume (MPV) and other inflammatory markers for APN.
Receiver operating characteristic curve of MPV and other inflammatory markers for APN.
| Variables | Area under curve | Standard error | 95% CI | |
|---|---|---|---|---|
| WBC (/μL) | 0.670 | 0.050 | 0.001 | 0.573–0.768 |
| ESR (mm/hr) | 0.626 | 0.051 | 0.018 | 0.526–0.727 |
| CRP (mg/L) | 0.764 | 0.044 | <0.001 | 0.678–0.850 |
| MPV (fL) | 0.641 | 0.051 | 0.008 | 0.541–0.742 |
APN: Acute pyelonephritis, WBC: white blood cell, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, MPV: Mean platelet volume.
Diagnostic accuracy of MPV for the prediction of APN.
| Variable | Sensitivity | Specificity | Positive predictive value | Negative predictive value | Positive LR | Negative LR |
|---|---|---|---|---|---|---|
| Tekin | ||||||
| MPV ≥ 8.2 | 81.4(67–92) | 86.3(74–94) | 83.3(69–93) | 84.6(72–93) | 5.93(5–7) | 0.22(0.1–0.5) |
| MPV ≥ 9.0 | 76.7(61–88) | 88.2(76–95) | 84.6(69–94) | 81.8(69–91) | 6.52(5–8) | 0.26(0.1–0.7) |
| MPV ≥ 9.5 | 53.5(38–69) | 94.1(84–99) | 88.5(70–97) | 70.6(58–81) | 9.09(7–12) | 0.49(0.2–1.6) |
| Our study | ||||||
| MPV ≥ 6.9 | 85.5(74–93) | 33.9(22–48) | 12.6(6–22) | 95.5(83–100) | 1.29(1–1.6) | 0.43(0.2–0.9) |
| MPV ≥ 7.4 | 45.2(33–58) | 82.1(70–91) | 21.9(8–43) | 93.1(86–97) | 2.53(1.4–4.7) | 0.67(0.5–0.9) |
| MPV ≥ 8.3 | 4.8(1–14) | 96.4(88–99.6) | 13.1(0.03–70) | 90.1(83–95) | 1.35(0.2–7.8) | 0.99(0.9–1.1) |
APN: Acute pyelonephritis, MPV: Mean platelet volume, LR: likelihood ratio.
Comparison of serial MPV levels after antibiotic therapy in UTI patients.
| Duration after antibiotics | Initial MPV (fL) | MPV after antibiotics (fL) | |
|---|---|---|---|
| 1 day (n = 17) | 7.14 ± 0.38 | 7.52 ± 0.58 | 0.031 |
| 2 days (n = 32) | 7.43 ± 0.49 | 7.49 ± 0.51 | 0.479 |
| 3 days (n = 30) | 7.23 ± 0.45 | 7.28 ± 0.54 | 0.613 |
| 4 days (n = 8) | 7.64 ± 0.87 | 7.6 ± 0.73 | 0.834 |
| 5 days (n = 8) | 7.55 ± 0.69 | 7.64 ± 0.66 | 0.564 |
| ≥ 6 days (n = 16) | 7.39 ± 0.41 | 7.13 ± 0.48 | 0.046 |
UTI: Urinary tract infection, MPV: Mean platelet volume.